A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Study title | A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis |
Disease or condition | Primary Sclerosing Cholangitis |
Study type | Interventional (clinical trial) |
Intervention/treatment | Volixibat (capsule) |
Phase | 2 |
Study site | Duke University |
Study location | Durham, NC |
Principal investigator | Julius Wilder |
Study coordinator name and email | Adele Gaskin; adele.gaskin@duke.edu |
Phone Contact | 919-684-0742 |
Clinicaltrials.gov link | https://clinicaltrials.gov/ct2/show/NCT04663308 |